Psyadon Pharmaceuticals, Inc. Announces Positive Interim Analysis of Phase 2 Study of Ecopipam for the Treatment of Tourette Syndrome
7/24/2012 10:19:15 AM
More...
|
Tourette Syndrome Association and Psyadon Pharmaceuticals, Inc. to Collaborate on a Drug Trial for Tourette Syndrome Treatment
5/11/2011 6:35:47 AM
More...
|
Psyadon Pharmaceuticals, Inc. Announces Dr. William Nyhan’s Participation in the Clinical Trial of Ecopipam in Lesch-Nyhan Disease
6/9/2010 9:51:12 AM
More...
|
Psyadon Pharmaceuticals, Inc. Announces Regulatory Milestones and the Initiation of a Clinical Trial of Ecopipam in Lesch-Nyhan Disease
2/9/2010 9:37:46 AM
More...
|
Psyadon Pharmaceuticals, Inc. Announces $8M Series A-1 Financing and In-License of Ecopipam from Schering Corporation
11/10/2008 7:18:07 AM
More...
|